juli is a digital health company that helps NHS-patients with chronic conditions understand and manage their health from home.

  • Improves health outcomes

  • Co-designed with patients
    to support their needs

  • Retention and engagement exceeding industry standards

Ease pressure on the NHS
by supporting self-management

Award winning:

Discover our latest publications:

Bipolar White paper

Results from our RCT study on depression

Results from our RCT study on asthma

Our Mission: Empowering patients
to reduce clinical burden

juli enables NHS-patients to identify triggers of their condition by tracking all data that might have an impact.

Patients are nudged towards healthier behaviour and improved medication adherence.

juli does all that
and more!

juli App Store

Engagement - the holy grail of health apps

Downloading health apps isn’t enough to drive impact. Users need to see a benefit, be engaged and stay interested enough to actually use them.  Easier said than done; most apps and especially health apps struggle to achieve user engagement and retention.

Interested to learn more about retention and engagement at juli? Read the full report here:

Retention of juli users after 30 days. (Industry average: 3.7%)

Engagement: More than half of the active juli users use the app at least twice per week.

“Using juli, I realized I was in a manic episode when I thought it was just everything going well. That meant I could take the right medications, and may have helped avoid such a crash when that episode ended.”

Drew H. (age 36)

“I just love the daily dares. I am such a gamer and try so hard to achieve my 5 points every day! It helps motivate me in a fun, non-intrusive way. And it feels great that the games I'm playing are actually good for my well being. juli makes keeping track of my wellness fun and I can see the benefits already.”

Lara M. (age 27)

“I had no idea that air pollution had such an effect on my depression! Sleep, activity - yes, but air pollution? But it does and taking this into account is one of the most helpful insights I've had in years. I would not have made the connection without juli's help.”

Robert K. (age 56)

Proven across conditions in 2 clinical trials

More than 500 people with depression or asthma used juli for eight weeks in two randomized controlled trial conducted by University College London.

Both studies reached their primary endpoints of statistically significant improvements in PHQ-8  and ACT scores compared to an active control group.

The usage of juli additionally led to 51% of the depression users achieving remission

The study is undergoing peer review and is currently available as a preprint.1 

Try juli today yourself!